A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Tradipitant (Primary)
- Indications Gastroparesis
- Focus Proof of concept; Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 02 Aug 2017 According to a Vanda Pharmaceuticals media release, results are expected in the first half of 2018.
- 15 Feb 2017 According to a Vanda Pharmaceuticals media release, results from the study are expected in the fourth quarter of 2017.
- 31 Jan 2017 Planned End Date changed from 1 Aug 2017 to 1 Nov 2017.